I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Blessing, John A.
679
results:
Search for persons
X
Format
Online (678)
Print (1)
Mediatypes
Articles (Online) (366)
Bookchapter (Online) (15)
OpenAccess-fulltext (297)
Sheet music (1)
Sorted by: Relevance
Sorted by: Year
?
1
A Phase II evaluation of ixabepilone (IND #59699, NSC #7104..:
Duska, Linda R.
;
Blessing, John A.
;
Rotmensch, Jacob
...
Gynecologic Oncology. 135 (2014) 1 - p. 44-48 , 2014
Link:
https://doi.org/10.1016/..
?
2
Gynecologic oncology group strategies to improve timeliness..:
Bialy, Sally
;
Blessing, John A
;
Stehman, Frederick B
..
Clinical Trials. 10 (2013) 4 - p. 617-623 , 2013
Link:
https://doi.org/10.1177/..
?
3
A phase II evaluation of trabectedin in the treatment of ad..:
Monk, Bradley J.
;
Blessing, John A.
;
Street, Daron G.
...
Gynecologic Oncology. 124 (2012) 1 - p. 48-52 , 2012
Link:
https://doi.org/10.1016/..
?
4
A phase II evaluation of belinostat and carboplatin in the ..:
Dizon, Don S.
;
Blessing, John A.
;
Penson, Richard T.
...
Gynecologic Oncology. 125 (2012) 2 - p. 367-371 , 2012
Link:
https://doi.org/10.1016/..
?
5
Phase II trial of nab-paclitaxel in the treatment of recurr..:
Alberts, David S.
;
Blessing, John A.
;
Landrum, Lisa M.
...
Gynecologic Oncology. 127 (2012) 3 - p. 451-455 , 2012
Link:
https://doi.org/10.1016/..
?
6
A phase II study of gemcitabine (gemzar, LY188011) in the t..:
Tait, David L.
;
Blessing, John A.
;
Hoffman, James S.
...
Gynecologic Oncology. 121 (2011) 1 - p. 118-121 , 2011
Link:
https://doi.org/10.1016/..
?
7
A phase II evaluation of weekly gemcitabine and docetaxel f..:
Miller, Brigitte E.
;
Blessing, John A.
;
Stehman, Frederick B.
...
Gynecologic Oncology. 118 (2010) 2 - p. 139-144 , 2010
Link:
https://doi.org/10.1016/..
?
8
Gynecologic Oncology Group quality assurance audits: analys..:
Blessing, John A
;
Bialy, Sally A
;
Whitney, Charles W
..
Clinical Trials. 7 (2010) 4 - p. 390-399 , 2010
Link:
https://doi.org/10.1177/..
?
9
A Phase II evaluation of weekly topotecan as a single agent..:
Fiorica, James V.
;
Blessing, John A.
;
Puneky, Louis V.
...
Gynecologic Oncology. 115 (2009) 2 - p. 285-289 , 2009
Link:
https://doi.org/10.1016/..
?
10
A phase II evaluation of pemetrexed (Alimta, LY231514, IND ..:
Miller, David Scott
;
Blessing, John A.
;
Drake, Richard D.
...
Gynecologic Oncology. 115 (2009) 3 - p. 443-446 , 2009
Link:
https://doi.org/10.1016/..
?
11
A phase II evaluation of bortezomib in the treatment of rec..:
Aghajanian, Carol
;
Blessing, John A.
;
Darcy, Kathleen M.
...
Gynecologic Oncology. 115 (2009) 2 - p. 215-220 , 2009
Link:
https://doi.org/10.1016/..
?
12
Phase II trial of cetuximab and carboplatin in relapsed pla..:
Secord, Angeles Alvarez
;
Blessing, John A.
;
Armstrong, Deborah K.
...
Gynecologic Oncology. 108 (2008) 3 - p. 493-499 , 2008
Link:
https://doi.org/10.1016/..
?
13
A phase II evaluation of weekly docetaxel in the treatment ..:
Garcia, Agustin A.
;
Blessing, John A.
;
Nolte, Susan
.
Gynecologic Oncology. 111 (2008) 1 - p. 22-26 , 2008
Link:
https://doi.org/10.1016/..
?
14
Evaluation of pemetrexed (Alimta, LY231514) as second line ..:
Miller, David Scott
;
Blessing, John A.
;
Bodurka, Diane C.
..
Gynecologic Oncology. 110 (2008) 1 - p. 65-70 , 2008
Link:
https://doi.org/10.1016/..
?
15
Fixed-dose rate gemcitabine plus docetaxel as first-line th..:
Hensley, Martee L.
;
Blessing, John A.
;
Mannel, Robert
.
Gynecologic Oncology. 109 (2008) 3 - p. 329-334 , 2008
Link:
https://doi.org/10.1016/..
1-15